Several studies have shown that tumor-infiltrating immune cell subsets, such as CD8+ T cells, DCs, and memory T cells, are increased in cancer patients and usually associated with a good prognosis, while immunosuppressive cell populations, regulatory T cells, and MDSCs exhibit the opposite trend (9, 41, 42). Here, CD8A is linked to neoplasm.